First Turn Management, LLC
DEL MAR, CA · CIK 1993440 · 13F filing filed 2024-11-07
SEC-registered investment adviser since 2023 · limited liability company
- Assets managed$900.1m
- Staff4 · 4 in investment roles
- Main clients (by assets)Sovereign wealth funds 90%, Private funds 10%
- Private funds2 (2 hedge) · $36.3m gross assets
- Main officeSolana Beach, CA
- Form ADV · 2026-03-25SEC adviser record
- Legal entityFIRST TURN MANAGEMENT, LLC (US)
- Kindhedge funds, institutions
- Others nearbySolana Beach, CA
As an employer
- Offices in1 country
- Private fundshedge 2
$631.6m
reported value
+2.7% vs Q2 2024
38positions
39.3%in top 10
13 new
6 added
19 reduced
11 sold out
vs Q2 2024
Holdings, Q3 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| NUVALENT INC COM | $36.7m5.82% | Added +106.8k |
| ARGENX SE ARGX | $29.5m4.67% | Reduced -25.5k |
| INSMED INC INSM | $26.0m4.12% | Added +33.1k |
| MIRUM PHARMACEUTICALS INC MIRM | $25.3m4.00% | Reduced -55.8k |
| VAXCYTE INC PCVX | $24.2m3.84% | Reduced -48.3k |
| AXSOME THERAPEUTICS INC AXSM | $22.9m3.63% | Reduced -82.0k |
| SYNDAX PHARMACEUTICALS INC SNDX | $22.9m3.62% | Added +546.8k |
| ASCENDIS PHARMA A/S SPONSORED ADR | $22.5m3.56% | Reduced -36.0k |
| NATERA INC NTRA | $19.8m3.13% | New |
| INTRA-CELLULAR THERAPIES INC ITCI | $18.6m2.95% | Reduced -92.5k |
| CRINETICS PHARMACEUTICALS IN CRNX | $18.1m2.86% | Reduced -15.9k |
| TRANSMEDICS GROUP INC TMDX | $17.9m2.84% | Reduced -25.5k |
| ARCELLX INC ACLX | $17.9m2.83% | New |
| BLUEPRINT MEDICINES CORP BPMC | $16.6m2.62% | Reduced -6.0k |
| VERONA PHARMA PLC VRNA | $16.5m2.61% | New |
| VERTEX PHARMACEUTICALS INC VRTX | $16.4m2.59% | Reduced -15.5k |
| BIOHAVEN LTD BHVN | $15.8m2.50% | Reduced -50.2k |
| ESTABLISHMENT LABS HLDGS INC ESTA | $15.4m2.45% | Reduced -13.0k |
| MERUS N V MRUS | $15.4m2.44% | Reduced -13.9k |
| ORIC PHARMACEUTICALS INC ORIC | $14.9m2.35% | Reduced -64.9k |
| INTUITIVE SURGICAL INC ISRG | $14.9m2.35% | Reduced -11.6k |
| HARROW INC HROW | $14.7m2.32% | New |
| VERA THERAPEUTICS INC VERA | $14.4m2.28% | Added +113.5k |
| BICARA THERAPEUTICS INC BCAX | $14.3m2.27% | New |
| GERON CORP GERN | $14.2m2.25% | New |
| ENLIVEN THERAPEUTICS INC ELVN | $13.7m2.16% | Added +121.8k |
| ADMA BIOLOGICS INC ADMA | $13.3m2.10% | New |
| DAY ONE BIOPHARMACEUTICALS I COM | $13.2m2.09% | New |
| REPLIGEN CORP RGEN | $13.2m2.09% | New |
| XENON PHARMACEUTICALS INC XENE | $12.8m2.03% | Reduced -14.7k |
| GLAUKOS CORP GKOS | $12.5m1.98% | New |
| KRYSTAL BIOTECH INC KRYS | $12.4m1.96% | Reduced -41.3k |
| CYTOKINETICS INC CYTK | $11.8m1.87% | Reduced -70.2k |
| ROCKET PHARMACEUTICALS INC RCKT | $11.5m1.82% | Added +60.3k |
| BRIDGEBIO PHARMA INC BBIO | $10.2m1.61% | New |
| RELAY THERAPEUTICS INC RLAY | $8.7m1.37% | New |
| ARS PHARMACEUTICALS INC SPRY | $8.6m1.36% | New |
| KALVISTA PHARMACEUTICALS INC KALV | $4.1m0.65% | Reduced -704.5k |
Sold out since Q2 2024
| Security | Value then |
|---|---|
| SAREPTA THERAPEUTICS INC SRPT | $28.7m181.7k shares |
| IMMUNOVANT INC IMVT | $18.4m695.4k shares |
| DEXCOM INC DXCM | $18.2m160.1k shares |
| ALPHATEC HLDGS INC ATEC | $14.2m1.4m shares |
| IDEAYA BIOSCIENCES INC IDYA | $14.0m397.8k shares |
| REVOLUTION MEDICINES INC RVMD | $12.8m329.5k shares |
| APOGEE THERAPEUTICS INC | $12.5m318.3k shares |
| SPYRE THERAPEUTICS INC SYRE | $10.9m464.4k shares |
| SILENCE THERAPEUTICS PLC SLN | $10.2m537.3k shares |
| IMMUNOCORE HLDGS PLC IMCR | $9.9m291.1k shares |
| DISC MEDICINE INC IRON | $6.3m138.9k shares |